The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Post-Transplantation Lymphoproliferative Disorders in Adults
Abstract
Solid-organ and hematopoietic stem-cell transplants are widely used for various life-threatening medical disorders. Prophylaxis against transplant rejection and graft-versus-host disease is often immunosuppressive and can increase the risk of lymphoproliferative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Hans, C. P. (2004) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 3,703
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Self-citationSpectrum of cancer risk among US solid organ transplant recipients
Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1592 · Cited by 1,524
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report
Opelz, G., & Döhler, B. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00325.x · Cited by 1,081
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301703 · Cited by 1,043
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
Paya, C. V., Fung, J. J., Nalesnik, M. A., Kieff, E., Green, M., Gores, G., Habermann, T. M., Wiesner, R. H., Swinnen, L. J., Woodle, E. S., et al. (1999) · Transplantation · doi:10.1097/00007890-199911270-00015 · Cited by 533
Self-citationStyczynski, J., van der Velden, W., Fox, C. P., Engelhard, D., de la Camara, R., Cordonnier, C., Ljungman, P., & on behalf of the Sixth European Conference on Infections in Leukemia, A. J. V. O. T. I. D. W. P. O. T. E. S. O. B. A. M. T. (.-I. (2016) · Haematologica · doi:10.3324/haematol.2016.144428 · Cited by 408
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Landgren, O., Gilbert, E. S., Rizzo, J. D., Socié, G., Banks, P. M., Sobocinski, K. A., Horowitz, M. M., Jaffe, E. S., Kingma, D. W., Travis, L. B., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178046 · Cited by 400
Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder
Walker, R. C., Marshall, W. F., Strickler, J. G., Wiesner, R. H., Velosa, J. A., Habermann, T. M., McGregor, C. G. A., & Paya, C. V. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1346 · Cited by 392
Self-citationvan Esser, J. W. J., van der Holt, B., Meijer, E., Niesters, H. G. M., Trenschel, R., Thijsen, S. F. T., van Loon, A. M., Frassoni, F., Bacigalupo, A., Schaefer, U. W., et al. (2001) · Blood · doi:10.1182/blood.v98.4.972 · Cited by 373
Stevens, S. J. C., Verschuuren, E. A. M., Pronk, I., van der Bij, W., Harmsen, M. C., The, T. H., Meijer, C. J. L. M., van den Brule, A. J. C., & Middeldorp, J. M. (2001) · Blood · doi:10.1182/blood.v97.5.1165 · Cited by 329
Evens, A. M., David, K. A., Helenowski, I., Nelson, B., Kaufman, D., Kircher, S. M., Gimelfarb, A., Hattersley, E., Mauro, L. A., Jovanovic, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4961 · Cited by 321
Identifying the patient at risk for post‐transplant lymphoproliferative disorder
Cockfield, S. M. (2001) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2001.003002070.x · Cited by 273
Lee, T. C., Savoldo, B., Rooney, C. M., Heslop, H. E., Gee, A. P., Caldwell, Y., Barshes, N. R., Scott, J. D., Bristow, L. J., O'Mahony, C. A., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01002.x · Cited by 259
Styczyński, J., Gil, L., Tridello, G., Ljungman, P. T., Donnelly, J. P., van der Velden, W. J. F. M., Omar, H., Martino, R., Halkes, C. J. M., Faraci, M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit391 · Cited by 252
Kanakry, J. A., Hegde, A. M., Durand, C. M., Massie, A. B., Greer, A. E., Ambinder, R. F., & Valsamakis, A. (2016) · Blood · doi:10.1182/blood-2015-09-672030 · Cited by 227
Wagner, H.-J., Wessel, M., Jabs, W., Smets, F., Fischer, L., Offner, G., & Bucsky, P. (2001) · Transplantation · doi:10.1097/00007890-200109270-00006 · Cited by 218
Quinlan, S. C., Pfeiffer, R. M., Morton, L. M., & Engels, E. A. (2011) · American Journal of Hematology · doi:10.1002/ajh.21911 · Cited by 214
Evens, A. M., Choquet, S., Kroll-Desrosiers, A. R., Jagadeesh, D., Smith, S. M., Morschhauser, F., Leblond, V., Roy, R., Barton, B., Gordon, L. I., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12211 · Cited by 189
Self-citationCancer and mTOR Inhibitors in Transplant Recipients
de Fijter, J. W. (2016) · Transplantation · doi:10.1097/tp.0000000000001447 · Cited by 154
Caillard, S., Porcher, R., Provôt, F., Dantal, J., Choquet, S., Dürrbach, A., Morélon, E., Moal, V., Janbon, B., Alamartine, É., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2344 · Cited by 147
Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab
Barnett, R., Barta, V. S., & Jhaveri, K. D. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1614298 · Cited by 136
Morscio, J., Dierickx, D., Ferreiro, J. L., Herreman, A., Loo, P. V., Bittoun, E., Verhoef, G. E. G., Matthys, P., Cools, J., Włodarska, I., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12196 · Cited by 120
Self-citationKanakry, J. A., Kasamon, Y. L., Bolaños‐Meade, J., Borrello, I., Brodsky, R. A., Fuchs, E. J., Ghosh, N., Gladstone, D. E., Gocke, C. D., Huff, C. A., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.07.013 · Cited by 118
Merlo, A., Turrini, R., Dolcetti, R., Martorelli, D., Muraro, E., Comoli, P., & Rosato, A. (2010) · Haematologica · doi:10.3324/haematol.2010.023689 · Cited by 106
Ferreiro, J. L., Morscio, J., Dierickx, D., Vandenberghe, P., Gheysens, O. S., Verhoef, G. E. G., Esteki, M. Z., Tousseyn, T., & Włodarska, I. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13558 · Cited by 105
Self-citationSchutt, S. D., Fu, J., Nguyen, H. D., Bastian, D. A., Heinrichs, J. L., Wu, Y., Liu, C., McDonald, D. G., Pidala, J., & Yu, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137641 · Cited by 101
Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders
Menter, T., Juškevičius, D., Alikian, M., Steiger, J., Dirnhofer, S., Tzankov, A., & Naresh, K. N. (2017) · British Journal of Haematology · doi:10.1111/bjh.14633 · Cited by 87
Kinch, A., Baecklund, E., Backlin, C., Ekman, T., Molin, D. L., Tufveson, G., Fernberg, P., Sundström, C., Pauksens, K., & Enblad, G. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.844853 · Cited by 83
Choquet, S., Varnous, S., Deback, C., Golmard, J., & Leblond, V. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12640 · Cited by 81
Fink, S., Gandhi, M. K., Nourse, J. P., Keane, C., Jones, K., Crooks, P., Jöhrens, K., Korfel, A., Schmidt, H. H., Neumann, S., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12858 · Cited by 65
Trappe, R. U., Choquet, S., Dierickx, D., Mollee, P. N., Zaucha, J. M., Dreyling, M. H., Dührsen, U., Tarella, C., Shpilberg, O., Sender, M., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13086 · Cited by 58
Self-citationGenetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders
Margolskee, E. M., Jobanputra, V., Jain, P., Chen, J., Ganapathi, K. A., Nahum, O., Levy, B., Morscio, J., Murty, V., Tousseyn, T., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.9400 · Cited by 55
The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders
Glotz, D., Chapman, J. R., Dharnidharka, V. R., Hanto, D. W., de Castro, M. C. R., Hirsch, H. H., Leblond, V., Mehta, A. K., Moulin, B., Pagliuca, A., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e318269e64f · Cited by 50
Courville, E. L., Yohe, S. L., Chou, D. B., Nardi, V., Lazaryan, A., Thakral, B., Nelson, A., Ferry, J. A., & Sohani, A. R. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.130 · Cited by 47
Furukawa, S., Wei, L., Krams, S., Esquivel, C., & Martinez, O. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12328 · Cited by 36
Vase, M. Ø., Maksten, E. F., Bendix, K., Hamilton-Dutoit, S. J., Andersen, C. Y., Møller, M. B., Sørensen, S. S., Jespersen, B., Kampmann, J., Søndergård, E., et al. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.966242 · Cited by 36
Cited by
Chambers, D. C., Cherikh, W. S., Harhay, M. O., Hayes, D., Hsich, E., Khush, K. K., Meiser, B., Potena, L., Rossano, J. W., Toll, A. E., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.08.001 · Cited by 1,269
Sehn, L. H., & Salles, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2027612 · Cited by 1,175
Khush, K. K., Cherikh, W. S., Chambers, D. C., Harhay, M. O., Hayes, D., Hsich, E., Meiser, B., Potena, L., Robinson, A., Rossano, J. W., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.08.004 · Cited by 960
Long-Term Survival after Kidney Transplantation
Hariharan, S., Israni, A. K., & Danovitch, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2014530 · Cited by 664
Khush, K. K., Cherikh, W. S., Chambers, D. C., Goldfarb, S., Hayes, D., Kucheryavaya, A. Y., Levvey, B. J., Meiser, B., Rossano, J. W., & Stehlik, J. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.07.022 · Cited by 555
Metadata
- Authors
- Dierickx, D., & Habermann, T. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-02-08
- Volume
- 378
- Issue
- 6
- Pages
- 549-562
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2786571997
- Cited by
- 481
- References
- 43
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.